| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.0017 | 1 |